Company intelligence / Profile preview

Neocella

Ownership: Private
Development stage: Other

Overview

NeoCell Bio-Technologies is a biotech company specializing in cytokine research, contract development, consulting, and biopharmaceutical manufacturing. The company provides end-to-end solutions from cell line development through clinical trial batch production and commercialization support. It does not appear to have its own proprietary drug pipeline but rather enables other companies' product development through its expertise in biologics, biosimilars, process optimization, formulation, analytical method development, and regulatory compliance.

Modalities: BiologicBiosimilarSmall molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Neocella.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neocella.

Explore the full profile